Company Filing History:
Years Active: 2015
Title: Mei-ling A Joiner: Innovator in Mitochondrial Research
Introduction
Mei-ling A Joiner is a prominent inventor based in Iowa City, IA (US). She has made significant contributions to the field of mitochondrial research, particularly in the development of therapeutic strategies targeting CaMKII activity. Her innovative work has the potential to impact the treatment and prevention of various diseases and disorders.
Latest Patents
Mei-ling A Joiner holds a patent for "Mitochondrial-targeted cationic nanoparticles comprising CaMKII inhibitors and uses thereof for treating and preventing diseases and disorders associated with CaMKII activity." This patent discloses compositions and methods aimed at addressing diseases linked to mitochondrial CaMKII activity.
Career Highlights
Joiner is affiliated with the University of Iowa Research Foundation, where she continues to advance her research. Her work is characterized by a commitment to understanding the complexities of mitochondrial function and its implications for health.
Collaborations
Mei-ling A Joiner collaborates with notable colleagues, including Mark E Anderson and Aliasger Karimjee Salem. These partnerships enhance her research efforts and contribute to the advancement of knowledge in her field.
Conclusion
Mei-ling A Joiner is a trailblazer in mitochondrial research, with a focus on innovative solutions for health challenges. Her contributions through patents and collaborations underscore her role as a key figure in scientific advancement.